MC13-0055 Development of a companion diagnostic for pegylated recombinant human PH20

L. O’Donnell 1, W. Sweet 1, X. Lu1, F. Meynier 2 , A. Derome3, L. Ganee4, F. Poyet-Gelas 3, A. Martin 5 , M. Casey6, N. Kertesz 7. 1Clinical Affairs, BioMerieux Inc., Durham, USA; 2BioMath, BioMerieux Inc., Grenoble, France; 3V & V, BioMerieux Inc., Grenoble, France; 4Product Design & Development, BioMerieux Inc., Grenoble, France; 5Oncology, GSK, Collegeville, USA; 6Statistics, GSK, Collegeville, USA; 7Pharmaceutical Liaison Manager, Response Genetics Inc., Los Angeles, USA